Insulet | Fremdkapital



Loan Capital Veränderung Datum
Abbott USD 12.93B 194M 2025-06
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 0 2025-06
Avanos Medical USD 95.7M 2.3M 2025-06
Baxter International USD 9.41B 962M 2025-03
Becton, Dickinson and Co. USD 17.53B 135M 2025-06
Boston Scientific USD 10.53B 1.56B 2025-03
Cardinal Health USD 7.14B 74M 2025-03
Cooper Companies USD 2.53B 34.4M 2025-04
Dexcom USD 1.24B 56.7M 2025-06
Edwards Lifesciences USD 597.8M 100K 2025-03
Eli Lilly USD 34.18B 319.4M 2025-06
Globus Medical USD 257K 41K 2025-03
ICU Medical USD 1.34B 150.83M 2025-06
Insulet USD 939M 673.3M 2025-06
Integra LifeSciences USD 1.23B 3.7M 2025-06
J&J USD 38.36B 7.7B 2025-03
Masimo USD 598.7M 37.3M 2025-06
Medtronic USD 25.64B 1.66B 2025-04
Merit Medical Systems USD 731.8M 1.12M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Solventum Corp 7.82B 2M 2025-06
Stryker USD 14.83B 446M 2025-06
Tandem Diabetes Care USD 309.15M 4.46M 2025-06
Teleflex USD 1.8B 5.68M 2025-06
West Pharmaceutical Services USD 202.6M 0 2025-06
Zimmer Biomet Holdings USD 6.75B 176.2M 2025-06


Insulet Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.